Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LUMO Lumos Pharma > Detailed Quotes

LUMO Lumos Pharma

Watchlist
5.045
-0.075-1.46%
Trading Session 12/01 14:56 ET
High
5.280
Open
5.100
Turnover
25.41K
Low
5.010
Pre Close
5.120
Volume
5.00K
Market Cap
42.26M
P/E(TTM)
Loss
52wk High
10.270
Shares
8.38M
P/E(Static)
Loss
52wk Low
4.465
Float Cap
25.41M
Bid/Ask %
20.00%
Historical High
36.720
Shs Float
5.04M
Volume Ratio
0.32
Historical Low
4.465
Dividend TTM
--
Div Yield TTM
--
P/B
0.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
5.27%
Avg Price
5.083
Lot Size
1
Float Cap
25.41M
Bid/Ask %
20.00%
Historical High
36.720
Shs Float
5.04M
Volume Ratio
0.32
Historical Low
4.465
Dividend TTM
--
P/B
0.62
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
5.27%
Avg Price
5.083
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.
CEO: Mr. Richard J. Hawkins
Market: NASDAQ
Listing Date: 11/11/2011
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist